Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 202 Records) |
Query Trace: Neoplasms and FGFR3[original query] |
---|
Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer. JAMA network open 2022 Dec 5 (12): e2245836. Liu Ze-Xian, Zhang Xiao-Long, Zhao Qi, Chen Yungchang, Sheng Hui, He Cai-Yun, Sun Yu-Ting, Lai Ming-Yu, Wu Min-Qing, Zuo Zhi-Xiang, Wang Wei, Zhou Zhi-Wei, Wang Feng-Hua, Li Yu-Hong, Xu Rui-Hua, Qiu Miao-Zh |
The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors. Clinical genitourinary cancer 2022 12 21 (1): 69-75. Chawla Neal S, Sayegh Nicolas, Tripathi Nishita, Govindarajan Ameish, Zengin Zeynep B, Phillip Errol J, Dizman Nazli, Meza Luis, Muddasani Ramya, Chehrazi-Raffle Alexander, Malhotra Jasnoor, Hsu JoAnn, Agarwal Neeraj, Pal Sumanta K, Tripathi Abhish |
Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer. Molecular oncology 2022 12 . Zhang Baifeng, Jia Peilin, Wang Jiayin, Pei Guangsheng, Wang Changxi, Pei Shimei, Li Xiangchun, Zhao Zhongming, Yi Xin, Guan Xin-Yuan, Huang |
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8638-8649. Vlachostergios Panagiotis J, Tamposis Ioannis A, Anagnostou Maria, Papathanassiou Maria, Mitrakas Lampros, Zachos Ioannis, Thodou Eleni, Samara Maria, Tzortzis Vassili |
Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients. Frontiers in genetics 2022 10 13 1011390. Zou Yuantao, Yuan Gangjun, Tan Xingliang, Luo Sihao, Yang Cong, Tang Yi, Wang Yanjun, Yao K |
Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. Journal for immunotherapy of cancer 2023 9 11 (9): . Yuxuan Song, Yun Peng, Caipeng Qin, Yulong Wang, Wenbo Yang, Yiqing Du, Tao |
Bladder cancer course, four genetic high-risk variants, and histopathological findings. EXCLI journal 2023 9 22 867-879. Thura Kadhum, Silvia Selinski, Meinolf Blaszkewicz, Jörg Reinders, Emanuel Roth, Frank Volkert, Daniel Ovsiannikov, Oliver Moormann, Holger Gerullis, Dimitri Barski, Thomas Otto, Svetlana Höhne, Jan G Hengstler, Klaus Gol |
RNA-seq profiling of upper tract urothelial carcinoma: bladder cancer consensus classification relevance, molecular heterogeneity and differential immune signatures. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 8 100300. Jacqueline Fontugne, Evanguelos Xylinas, Clementine Krucker, Victoria Dixon, Clarice S Groeneveld, Ugo Pinar, Gianluigi Califano, Margot Bucau, Jerome Verine, Francois Desgrandchamps, Jean-Francois Hermieu, Francois Radvanyi, Yves Allory, Alexandra Masson-Lecom |
The genomic landscape associated with resistance to aromatase inhibitors in breast cancer. Genomics & informatics 2023 7 21 (2): e20. Kirithika Sadasivam, Jeevitha Priya Manoharan, Hema Palanisamy, Subramanian Vidyalaksh |
Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits. Frontiers in oncology 2023 7 13 1105474. Hui Wang, Qiaoyan Liu, Mi Zhang, Juan Zhang, Ran Ran, Yingying Ma, Jiao Yang, Fan Wang, Shujuan He, Xiaoai Zhao, Le Wang, Lingxiao Zhang, Danfeng Dong, Jin Ya |
Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing. Cureus 2023 6 15 (6): e39818. Mohiuddin M Taher, Najwa A Bantan, Mustafa H Alwalily, Muhammad Saeed, Nuha M Taher, Meriem Bouzidi, Raid A Jastania, Kamal B Balkhoyo |
Different Mutational Landscape in HPV-induced and HPV-independent Invasive Penile Squamous Cell Cancers. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 6 100250. Mikhail S Ermakov, Karl Kashofer, Sigrid Regau |
Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
LDL receptor related protein 1 is an adverse prognostic biomarker that correlates with stromal remodeling and macrophages infiltration in bladder cancer. Frontiers in immunology 2023 5 14 1113756. YiHeng Du, YiZheng Liu, Jin Cao, Xiang Jiang, Yi Wang, Jiang Yu, Bo Wang, XiZhi Wang, BoXin X |
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. European urology 2023 5 . Stella Koutros, Lambertus A Kiemeney, Parichoy Pal Choudhury, Roger L Milne, Evangelina Lopez de Maturana, Yuanqing Ye, Vijai Joseph, Oscar Florez-Vargas, Lars Dyrskjøt, Jonine Figueroa, Diptavo Dutta, Graham G Giles, Michelle A T Hildebrandt, Kenneth Offit, Manolis Kogevinas, Elisabete Weiderpass, Marjorie L McCullough, Neal D Freedman, Demetrius Albanes, Charles Kooperberg, Victoria K Cortessis, Margaret R Karagas, Alison Johnson, Molly R Schwenn, Dalsu Baris, Helena Furberg, Dean F Bajorin, Olivier Cussenot, Geraldine Cancel-Tassin, Simone Benhamou, Peter Kraft, Stefano Porru, Angela Carta, Timothy Bishop, Melissa C Southey, Giuseppe Matullo, Tony Fletcher, Rajiv Kumar, Jack A Taylor, Philippe Lamy, Frederik Prip, Mark Kalisz, Stephanie J Weinstein, Jan G Hengstler, Silvia Selinski, Mark Harland, Mark Teo, Anne E Kiltie, Adonina Tardón, Consol Serra, Alfredo Carrato, Reina García-Closas, Josep Lloreta, Alan Schned, Petra Lenz, Elio Riboli, Paul Brennan, Anne Tjønneland, Thomas Otto, Daniel Ovsiannikov, Frank Volkert, Sita H Vermeulen, Katja K Aben, Tessel E Galesloot, Constance Turman, Immaculata De Vivo, Edward Giovannucci, David J Hunter, Chancellor Hohensee, Rebecca Hunt, Alpa V Patel, Wen-Yi Huang, Gudmar Thorleifsson, Manuela Gago-Dominguez, Pilar Amiano, Klaus Golka, Mariana C Stern, , Wusheng Yan, Jia Liu, Shengchao Alfred Li, Shilpa Katta, Amy Hutchinson, Belynda Hicks, William A Wheeler, Mark P Purdue, Katherine A McGlynn, Cari M Kitahara, Christopher A Haiman, Mark H Greene, Thorunn Rafnar, Nilanjan Chatterjee, Stephen J Chanock, Xifeng Wu, Francisco X Real, Debra T Silverman, Montserrat Garcia-Closas, Kari Stefansson, Ludmila Prokunina-Olsson, Núria Malats, Nathaniel Rothm |
Genomic profiles of Indonesian colorectal cancer patients. F1000Research 2023 5 11 443. Murdani Abdullah, Sofy Meilany, Hidayat Trimarsanto, Safarina G Malik, Ninik Sukartini, Firhat Idrus, Saskia A Nursyirwan, Virly N Muzellina, Rabbinu R Pribadi, Amanda P Utari, Hasan Maulahela, Ari F Sy |
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis. Frontiers in genetics 2023 4 14 1097179. Yuda Lin, Tengfei Li, Zhuolun Li, Chong Shen, Zhouliang Wu, Zhe Zhang, Zhi Li, Shaobo Yang, Zejin Wang, Peng Li, Chong Fu, Jian Guo, Hailong |
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
Expression of EPB41L2 in Cancer-Associated Fibroblasts: Prognostic Implications for Bladder Cancer and Response to Immunotherapy. Archives of medical research 2023 12 55 (1): 102927. Tianqi Wang, Guixin Ding, Xiaoyu Wang, Yuanshan Cui, Xiaohong Ma, Jian Ma, Jitao |
Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic Strategy. Cancer research and treatment 2023 12 . Bokyung Ahn, Doeun Kim, Kye Jin Park, Ja-Min Park, Sun Young Yoon, Bumsik Hong, Yong Mee Cho, Deokhoon K |
Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer science 2023 12 . Daichi Tamura, Masakazu Abe, Hayato Hiraki, Noriyuki Sasaki, Akiko Yashima-Abo, Daiki Ikarashi, Renpei Kato, Yoichiro Kato, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Kazuhiro Maejima, Shota Sasagawa, Masashi Fujita, Yutaka Suzuki, Hidewaki Nakagawa, Takeshi Iwaya, Satoshi S Nishizuka, Wataru Oba |
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer. Molecular cancer 2023 11 22 (1): 185. Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, Takuya Tsujino, Kazuki Nishimura, Mitsuaki Ishida, Takuo Hayashi, Ayako Ura, Takaya Ohno, Shogo Yamazaki, Keita Nakamori, Shoko Kinoshita, Ryoichi Maenosono, Masahiko Ajiro, Yuki Yoshikawa, Tomoaki Takai, Takeshi Tsutsumi, Kohei Taniguchi, Tomohito Tanaka, Kiyoshi Takahara, Tsuyoshi Konuma, Teruo Inamoto, Yoshinobu Hirose, Fumihito Ono, Yuichi Shiraishi, Akihide Yoshimi, Haruhito Azu |
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer. European journal of cancer (Oxford, England : 1990) 2023 10 195 113368. Clara Helal, Cédric Pobel, Arnaud Bayle, Damien Vasseur, Claudio Nicotra, Félix Blanc-Durand, Natacha Naoun, Alice Bernard-Tessier, Anna Patrikidou, Emeline Colomba, Ronan Flippot, Alina Fuerea, Nathalie Auger, Maud Ngo Camus, Benjamin Besse, Ludovic Lacroix, Etienne Rouleau, Santiago Ponce, Antoine Italiano, Yohann Lori |
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation Sequencing. Journal of clinical medicine 2024 4 13 (5): . Seong Hyeon Yu, Sung Sun Kim, Shinseung Kim, Hyungki Lee, Taek Won Ka |
A novel exosome-related prognostic risk model for thyroid cancer. Asia-Pacific journal of clinical oncology 2024 4 . Junfeng Qi, Hanshan Cheng, Long Su, Jun Li, Fei Che |
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts. Histopathology 2024 1 . Veronika Bahlinger, Annalena Branz, Pamela L Strissel, Reiner Strick, Fabienne Lange, Carol I Geppert, Niklas Klümper, Michael Hölzel, Sven Wach, Helge Taubert, Danijel Sikic, Bernd Wullich, Miriam Angeloni, Fulvia Ferrazzi, Lauri Diehl, Maria Kovalenko, Emon Elboudwarej, Juliane M Jürgensmeier, Arndt Hartmann, Markus Eckste |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: